Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

The first patient enrolled in a planned international clinical trial has been treated at HonorHealth Research Institute with a new type of immune therapy for those with a rare muscle-weakness disease ...

Bacteria carry countless hidden treasures in their DNA—fragments that could hold the key to new medicines. But how do you ...

Powerful llama-derived antibodies could be the key to stopping not just current SARS viruses, but future ones too. Scientists ...

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE RUSSIAN ...

In February and March 2025, visitors to Yala National Park stood in disbelief as torrents of brown water surged across ...

Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS ...

Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska 68588-0304, United States Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, Lincoln, ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market ...

Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of ...

Abstract #： 306-OR Presentation Form: Oral presentation Time: 2025 June 23, 14:15 PM – 14:30 PM（CST） Presenter: Dr. Lei Qian, Innovent Biologics Title: A novel antibody-peptide conjugate targeting ...

Scientists have identified a class of small antibodies that provide strong protection against a broad range of SARS-related ...